Skip to content

OrbiMed Capital GP VIII LLC, Director at Sionna Therapeutics, sold SION on Jul 7, 2026

Data as of Oct 16

▼ SELL$3.9M85,918 shares at $44.86OrbiMed Capital GP VIII LLC DirectorSION Sionna Therapeutics, Inc.
Watch SION
Traded
Jul 7, 2026
Disclosed
Jul 9, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

OrbiMed Capital GP VIII LLC, Director at Sionna Therapeutics, sold SION on Jul 7, 2026TRADEDDISCLOSED
SIONSimilar stocks (XLV — its sector index fund), rebased to SION's price on the disclosure day
SION since disclosure
−91.3%
after the sale
Similar stocks (XLV) since disclosure
+9.0%
XLV — its sector index fund

Change in closing price from Jul 9, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLOrbimed Advisors LLC DirectorSION Sionna Therapeutics, Inc.$3.9Mdisclosed Jul 9 · filed 2 days after the trade

See every trade on SION →